The CEO foresees a "snowball effect" of life sciences companies coming to Dallas, but a couple things need to happen first.

BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

Michael Breen, CEO of GT Biopharma, said current cancer treatments are 80 years old.

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific ...

Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...

Pharmacy is the drug developer, overseeing clinical studies and formulation. Check the NIRF 2025 ranking of the best pharmacy ...

Students of Guru Gobind Singh Indraprastha University will now benefit from expanded research opportunities, hands-on ...

Partnering Platform Now Open for RegistrationSAN FRANCISCO--(BUSINESS WIRE)--#biotechshowcase--Biotech Showcase™ returns to ...

The actor narrates a new documentary that expresses skepticism toward vaccines and includes discredited science ...

Sartorius Group is expected to continue delivering high-single digit CER sales growth in 2026, supported by strong consumables performance. JPMorgan maintains an Overweight rating with price targets ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...